Reinnervate to host free webinar discussing the benefits and applications of 3D cell culture

Dec. 8, 2011 - PRLog -- Reinnervate, the expert in making routine 3D cell culture a reality, will host an informative webinar discussing the benefits of using 3D cell culture models to study a wide range of biological processes. The free event, hosted by reinnervate’s Chief Scientific Officer Professor Stefan Przyborski, will be run twice on the 16th December 2011, first at 9am EST (2pm GMT) then again at 12pm EST (5pm GMT). As well as the opportunity to interact and ask questions, participants will be presented with evidence showing that cells grown using reinnervate’s novel alvetex® 3D scaffold display enhanced cell viability, differentiation and function when compared to those grown using conventional 2D culture models.

To find out more about alvetex and discover how it can help take your research to the next level, register for the free webinar now using the simple online registration form.

Alternatively, visit www.reinnervate.com for more information.

About reinnervate

Reinnervate is an innovative life sciences company dedicated to making routine 3D cell culture a reality for researchers in academia and in the pharmaceutical and related industries.

Reinnervate’s core technology is alvetex®, a unique and proprietary scaffold that enables routine 3D cell culture in the laboratory. Alvetex® provides a nanoscale environment that supports genuine homogeneous 3D cell growth. Cells grown using alvetex form complex 3D tissue cultures which more closely mimic normal in-vivo cell growth and the formation of tissues in the body than conventional techniques. The use of alvetex-derived 3D cell cultures can provide researchers with greater insight into how cells behave in the body in response to external factors (such as drug candidates) than is currently possible with existing 2D or other emerging 3D cell culture technologies.

Reinnervate has generated significant data, which have been published extensively in peer-reviewed publications, exemplifying the use of alvetex in a large number of cell types and applications. Alvetex® has been launched globally in several formats: a 12-well culture plate, 6-well and 12-well inserts and a deep well petri dish.  

Reinnervate continues to develop its technology for use in the 3D cell culture. During 2012 Reinnervate will deliver further innovative products to help researchers improve the growth and function of their cultured cells

Reinnervate was founded in 2002 based on the pioneering research of Professor Stefan Przyborski and his lab at Durham University, UK, and is funded by NorthStar Equity Investors (NSEI), management and private investors.